Free Newsletter
Lilly CEO: Pharma will snub Boston
Free newsletter via e-mail
Tools
Eli Lilly CEO John Lechleiter isn't happy with new Massachusetts legislation governing the way drugmakers market their products to doctors: He's saying that the limits will hamper innovation and force companies to reconsider expanding in the state. Report
Comments
By Anonymous | Posted 2:59pm | January 21, 2009
Congratulations Lilly!! It's about time pharma stands up to socialization.
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
